乙酰氧肟酸，一种尿素酶抑制剂，可抑制补体蛋白C3和C4的共价结合反应。 - Suppr | 超能文献

Acetohydroxamate, a urease inhibitor, inhibits the covalent binding reaction of complement proteins C3 and C4.

作者信息

Sim E, Jones A, Stanley L

出版信息

Acta Pharmacol Toxicol (Copenh). 1985 Oct;57(4):304-6. doi: 10.1111/j.1600-0773.1985.tb00048.x.

DOI:10.1111/j.1600-0773.1985.tb00048.x

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Acetohydroxamate, a urease inhibitor, inhibits the covalent binding reaction of complement proteins C3 and C4.乙酰氧肟酸，一种尿素酶抑制剂，可抑制补体蛋白C3和C4的共价结合反应。

Acta Pharmacol Toxicol (Copenh). 1985 Oct;57(4):304-6. doi: 10.1111/j.1600-0773.1985.tb00048.x.

2

Suppression of Fc Receptor and C4.C3 receptors of the granulocytes from patients with systemic lupus erythematosus.系统性红斑狼疮患者粒细胞的Fc受体和C4、C3受体的抑制作用

J Rheumatol. 1981 Nov-Dec;8(6):910-6.

3

A decrease in complement is associated with increased renal and hematologic activity in patients with systemic lupus erythematosus.系统性红斑狼疮患者体内补体水平降低与肾脏及血液学活性增加相关。

Arthritis Rheum. 2001 Oct;44(10):2350-7. doi: 10.1002/1529-0131(200110)44:10<2350::aid-art398>3.0.co;2-a.

4

Hypercatabolism of C3 and C4 in active and inactive systemic lupus erythematosus.活动期和非活动期系统性红斑狼疮中C3和C4的高分解代谢

Ann Rheum Dis. 1989 Feb;48(2):153-9. doi: 10.1136/ard.48.2.153.

5

Antiphospholipid Antibodies are Associated with Low Levels of Complement C3 and C4 in Patients with Systemic Lupus Erythematosus.抗磷脂抗体与系统性红斑狼疮患者补体C3和C4水平降低有关。

Scand J Immunol. 2016 Aug;84(2):95-9. doi: 10.1111/sji.12445.

6

Increased amounts of C4-containing immune complexes and inefficient activation of C3 and the terminal complement pathway in a patient with homozygous C2 deficiency and systemic lupus erythematosus.纯合子C2缺乏症和系统性红斑狼疮患者体内含C4免疫复合物数量增加，C3及补体终末途径激活效率低下。

Scand J Immunol. 1990 Jan;31(1):59-64. doi: 10.1111/j.1365-3083.1990.tb02743.x.

7

C4-binding protein in sera of patients with systemic lupus erythematosus and mixed essential cryoglobulinemia.系统性红斑狼疮和混合性原发性冷球蛋白血症患者血清中的C4结合蛋白

Complement. 1984;1(2):81-6. doi: 10.1159/000467819.

8

The in vivo metabolism of the third component of complement in systemic lupus erythematosus.

Arthritis Rheum. 1977 Sep-Oct;20(7):1304-13. doi: 10.1002/art.1780200702.

9

The covalent binding reaction of C3 and C4.C3与C4的共价结合反应

Ann N Y Acad Sci. 1983;421:246-58. doi: 10.1111/j.1749-6632.1983.tb18113.x.

10

CR1 and the cell membrane proteins that bind C3 and C4. A basic and clinical review.CR1以及与C3和C4结合的细胞膜蛋白。基础与临床综述。

Immunol Res. 1987;6(3):192-209. doi: 10.1007/BF02918091.

引用本文的文献

1

Microbial ureases: significance, regulation, and molecular characterization.微生物脲酶：意义、调控及分子特征

Microbiol Rev. 1989 Mar;53(1):85-108. doi: 10.1128/mr.53.1.85-108.1989.

2

Metabolites of procainamide and practolol inhibit complement components C3 and C4.普鲁卡因酰胺和心得宁的代谢产物会抑制补体成分C3和C4。

Biochem J. 1988 Apr 15;251(2):323-6. doi: 10.1042/bj2510323.